• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体病毒粒子相关肽聚糖水解酶:潜在的新型酶类抗生素。

Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics.

机构信息

Instituto de Productos Lácteos de Asturias. IPLA-CSIC, Paseo Rio Linares sn Villaviciosa Asturias , Spain.

出版信息

Crit Rev Microbiol. 2013 Nov;39(4):427-34. doi: 10.3109/1040841X.2012.723675. Epub 2012 Sep 20.

DOI:10.3109/1040841X.2012.723675
PMID:22991936
Abstract

Virion-associated peptidoglycan hydrolases (VAPGH) are phage-encoded lytic enzymes that locally degrade the peptidoglycan (PG) of the bacterial cell wall during infection. In contrast to endolysins, PGHs that mediate lysis of the host bacteria at the end of the lytic cycle to release of phage progeny, the action of VAPGHs generates a small hole through which the phage tail tube crosses the cell envelope to eject the phage genetic material at the beginning to the infection cycle. The antimicrobial activity of VAPGHs was first discovered through the observation of the phenomenon of 'lysis from without', in which the disruption of the bacterial cell wall occurs prior to phage production and is caused by a high number of phages adsorbed onto the cell surface. Based on a unique combination of properties of VAPGHs such as high specificity, remarkable thermostability, and a modular organization, these proteins are potential candidates as new antibacterial agents, e.g. against antibiotic-resistant bacteria in human therapy and veterinary as well as biopreservatives in food safety, and as biocontrol agents of harmful bacteria in agriculture. This review provides an overview of the different VAPGHs discovered to date and their potential as novel antimicrobials.

摘要

病毒相关肽聚糖水解酶(VAPGH)是噬菌体编码的溶菌酶,可在感染过程中局部降解细菌细胞壁的肽聚糖(PG)。与内溶素不同,PGHs 在溶菌周期结束时介导宿主细菌的裂解,以释放噬菌体后代,而 VAPGHs 的作用是产生一个小孔,噬菌体尾管穿过细胞包膜,在感染周期的开始时将噬菌体的遗传物质喷射出来。VAPGHs 的抗菌活性最初是通过观察“从外向内裂解”现象发现的,在这种现象中,噬菌体产生之前就发生了细菌细胞壁的破坏,这是由于大量噬菌体吸附在细胞表面上引起的。基于 VAPGHs 的独特性质组合,如高度特异性、显著的热稳定性和模块化组织,这些蛋白质是作为新型抗菌剂的潜在候选物,例如用于人类治疗和兽医中的抗生素耐药菌,以及食品安全中的生物防腐剂,以及农业中有害细菌的生物防治剂。本文综述了迄今为止发现的不同 VAPGH 及其作为新型抗菌剂的潜力。

相似文献

1
Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics.噬菌体病毒粒子相关肽聚糖水解酶:潜在的新型酶类抗生素。
Crit Rev Microbiol. 2013 Nov;39(4):427-34. doi: 10.3109/1040841X.2012.723675. Epub 2012 Sep 20.
2
Endolysins as antimicrobials.溶菌素作为抗菌剂。
Adv Virus Res. 2012;83:299-365. doi: 10.1016/B978-0-12-394438-2.00007-4.
3
Taking aim on bacterial pathogens: from phage therapy to enzybiotics.瞄准细菌病原体:从噬菌体疗法到酶生素
Curr Opin Microbiol. 2007 Oct;10(5):461-72. doi: 10.1016/j.mib.2007.08.002. Epub 2007 Sep 27.
4
Phage-Derived Peptidoglycan Degrading Enzymes: Challenges and Future Prospects for In Vivo Therapy.噬菌体衍生的肽聚糖降解酶:体内治疗的挑战和未来前景。
Viruses. 2018 May 29;10(6):292. doi: 10.3390/v10060292.
5
Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process.噬菌体编码的病毒体相关酶在感染过程中克服碳水化合物屏障。
Appl Microbiol Biotechnol. 2017 Apr;101(8):3103-3119. doi: 10.1007/s00253-017-8224-6. Epub 2017 Mar 23.
6
Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications.具有抗菌应用的噬菌体和肽聚糖降解酶。
Recent Pat Biotechnol. 2007;1(2):113-22. doi: 10.2174/187220807780809463.
7
Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.具有保守肽聚糖裂解位点的进化上不同的噬菌体溶菌酶可保护小鼠免受耐甲氧西林金黄色葡萄球菌(MRSA)感染。
J Antimicrob Chemother. 2015 May;70(5):1453-65. doi: 10.1093/jac/dku552. Epub 2015 Jan 27.
8
Bacteriophage endolysins as a novel class of antibacterial agents.噬菌体溶菌酶作为一类新型抗菌剂。
Exp Biol Med (Maywood). 2006 Apr;231(4):366-77. doi: 10.1177/153537020623100402.
9
Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1.从 Myoviridae 噬菌体 OBP、201φ2-1 和 PVP-SE1 中鉴定出的模块化噬菌体溶菌酶的特性。
PLoS One. 2012;7(5):e36991. doi: 10.1371/journal.pone.0036991. Epub 2012 May 15.
10
From endolysins to Artilysin®s: novel enzyme-based approaches to kill drug-resistant bacteria.从内溶素到Artilysin®s:基于新型酶的抗耐药菌方法
Biochem Soc Trans. 2016 Feb;44(1):123-8. doi: 10.1042/BST20150192.

引用本文的文献

1
Use of the bacteriophage-derived endolysin CHAPK-SH3blys as a potent novel treatment for biofilm-associated wound infections.将噬菌体衍生的内溶素CHAPK-SH3blys用作治疗生物膜相关伤口感染的一种有效的新型疗法。
Microbiol Spectr. 2025 Sep 2;13(9):e0071625. doi: 10.1128/spectrum.00716-25. Epub 2025 Aug 5.
2
[Phage endolysins-a novel class of antibacterial agents with a wide range of applications].[噬菌体溶菌酶——一类具有广泛应用的新型抗菌剂]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2025 May 6. doi: 10.1007/s00103-025-04059-9.
3
Phage Endolysins as Promising and Effective Candidates for Use Against Uropathogenic .
噬菌体溶菌酶作为对抗尿路致病性细菌的有前景且有效的候选物
Viruses. 2025 Apr 13;17(4):560. doi: 10.3390/v17040560.
4
The Chinese gut virus catalogue reveals gut virome diversity and disease-related viral signatures.中国肠道病毒目录揭示了肠道病毒组的多样性和与疾病相关的病毒特征。
Genome Med. 2025 Mar 26;17(1):30. doi: 10.1186/s13073-025-01460-6.
5
Analysis of a novel phage as a promising biological agent targeting multidrug resistant Klebsiella pneumoniae.一种新型噬菌体作为靶向多重耐药肺炎克雷伯菌的有前景生物制剂的分析
AMB Express. 2025 Mar 5;15(1):37. doi: 10.1186/s13568-025-01846-0.
6
Exploring Viral Interactions in Species: In Silico Analysis of Prophage Prevalence and Antiviral Defenses.探索物种中的病毒相互作用:原噬菌体流行率和抗病毒防御的计算机模拟分析
Life (Basel). 2025 Jan 27;15(2):187. doi: 10.3390/life15020187.
7
The Unique Capability of Endolysin to Tackle Antibiotic Resistance: Cracking the Barrier.内溶素应对抗生素耐药性的独特能力:突破障碍
J Xenobiot. 2025 Jan 25;15(1):19. doi: 10.3390/jox15010019.
8
A metagenome-wide study of the gut virome in chronic kidney disease.一项关于慢性肾病患者肠道病毒组的宏基因组学研究。
Theranostics. 2025 Jan 2;15(5):1642-1661. doi: 10.7150/thno.101601. eCollection 2025.
9
Isolation and characterization of a broad-spectrum bacteriophage against multi-drug resistant Escherichia coli from waterfowl field.从水禽养殖场分离并鉴定一种针对多重耐药性大肠杆菌的广谱噬菌体。
Poult Sci. 2025 Feb;104(2):104787. doi: 10.1016/j.psj.2025.104787. Epub 2025 Jan 10.
10
Phage therapy: A novel approach against multidrug-resistant pathogens.噬菌体疗法:一种对抗多重耐药病原体的新方法。
3 Biotech. 2024 Oct;14(10):256. doi: 10.1007/s13205-024-04101-8. Epub 2024 Sep 30.